9th international conference on biomarkers

conferenceseries.com Biomarkers Congress 2017conferenceseries.com

http://molecular-cancer-biomarkers.conferenceseries.com/asiapacific/

Conference Secretariat2360 Corporate Circle, Suite 400 Henderson

NV 89074-7722, USAConference Series

Direct: (702) 508-5200 Ext: 8083Tel: +1 (650) 889 4686

Email: [email protected]

Program

October 26 -28, 2017 Osaka, Japan

9th International Conference on BiomarkersExpert Speakers. Evidence based. Health Care Professionals.

Seating is LimitedRegister Today!



Confreence Highlights•MolecularBiomarkersDiscovery•TranslationalBiomarkers•Biomarkers:ValidationandVerification•ClinicalBiomarkers•Biomarkers:Cancers•BiomarkersandDiseases•CellFreeBiomarkers•PredictiveCancerBiomarkers•AdvancesofBiomarkerTesting•BiomarkerandPersonalizedMedicine•CompanionDiagnostics•Biomarkers&Pharmacology•MolecularImagingandDynamics

** Speaker Slots are Available **



Organizing Committee Members

Dimitrios H RoukosFounding Director

Centre for Biosystems & Synthetic Genomic Network Medicine, Greece

Yasufumi SatoProfessor

Tohoku UniversityJapan

Jianhua LuoProfessor

University of Pittsburgh United States

Harish PantSenior Investigator

NINDSUSA

Shivendra V SinghProfessor/Associate Director

University of Pittsburgh USA

Kaushala Prasad MishraVice Chancellor

Nehru Gram Bharati UniversityIndia

Kirti KaulSenior ScientistMedbiomarkers

Germany

Sheikh RaisuddinHead

Centre for Translational & Clinical Research, India



Top Participating Organisations



KeynoteForumsTitle:BiomarkersInThyroidCancerRaniKanthan,UniversityofSaskatchewan,RoyalUniversityHospital,CANADATitle:Vasohibin-1andVasohibin-2asbiomarkersofcancersYasufumiSato,Professor,Associateeditor,president,TohokuUniversity,JapanTitle:EGFandTGFαmotogenicactiviesaremediatedbytheEGFreceptor:IdentificationofsignallingpathwaysinvolvedinoralcancerAyeMyatThwe,UniversityofDundee,UnitedKingdom

ScientificSessionsTitle:OverexpressionofCofactorofBRCA1inHepG2Cells:AStepTowardsUnderstandingtheRoleofCOBRA1inHepatocellularCarcinomaRazanJamilMasad,TheAmericanUniversityinCairo,JordenTitle:RemoteControlofLight-TriggeredVirotherapyS.-JaTseng,NationalTaiwanUniversityCollegeofMedicine,TaiwanTitle:Intakeofchemopreventiveantioxidantdietarysupplementshasimpactonlymphocytestress-relatedbiomarkersinhealthydogsTamaraP.Kondratyuk,UniversityofHawaii,UnitedStatesTitle:Adverseevents(AEs)AfterFirst-LineTargetTherapyforAdvancedNon-SmallCellLungCancerPatientsinTaiwanZhi-XuanLin,ChangJungChristianUniversity,TaiwanTitle:GutMicrobiomeRegulationofCancerStemcellsandColonCarcinogenesisAdhipP.N.Majumdar,WayneStateUniversity,USATitle:InvestigationofLRRC24,aputativenegativeregulatorofErbBreceptortyrosinekinasesAmberAndrews,UnitedStatesTitle:ClinicalSignificanceofExpressionofCripto-1InPatientsofSquamousCellCarcinomaOfOropharynxMallupattuSumanthKumar,PostgraduateInstituteofMedicalEducation&Research,IndiaTitle:ThepossibilitiesofusesofbiomarkerstotheestimationofexposureofpotatotoherbicidesBarbaraSawicka,UniversityofLifeSciencesinLublin,PolandTitle:Validityofprostatehealthindexandpercentageof[-2]pro-prostate-specificantigenasnovelbiomarkersinthediagnosisofprostatecancerFirstreportedOmanitertiaryhospitalsexperienceSafanaSalimAlSaidi,MINISTRYOFHealthChemicalPathologistMD,MuscatTitle:Livingorganismsinfluenceonenvironmentalconditions:pHmodulationbyamphibianembryosversusaluminumtoxicityJorgeHerkovits,InstitutodeCienciasAmbientalesySalud,FundacionPROSAMA,ArgentinaTitle:ConcentrationLevelsofIL-10andTGFαCytokinesinPatientswithHPVDNAPositiveandNegativeCervicalLesionsHushamY.M.AliBayazed,UniversityofZakho,IraqTitle:EGFandTGFαmotogenicactiviesaremediatedbytheEGFreceptor:IdentificationofsignallingpathwaysinvolvedinoralcancerAyeMyatThwe,UniversityofDundee,UnitedKingdomTitle:ClinicalimplicationofcellfreemicroRNA-200aexpressionasprognosticindicatorforbreastcancerpatientsMirzaMasroor,DelhiUniversity,IndiaTitle:AccesstoHealth–BreastCancerAwarenessandScreeningCampsinRuralIndiaAbhinavChaturvedi,CEOandFounder,InnoplexusAG,IndiaTitle:ConcordantassociationvalidatesMGMTmethylationandproteinexpressionasfavorableprognosticfactorsingliomapatientsonTemozolomideIqbalQasim,Sher-I-KashmirInstituteofMedicalSciences,India

SpeakerSlotsAvailableNOTE:Programissubjecttochangewithfinalallotmentofthespeakerslots

Tentative Program



Previous Speakers

Trevor g marshallAutoimmunity Research Foundation

USA

Mohammad O HoqueJohns Hopkins University

USA

Masamichi HayashiNagoya University School of

Medicine, Japan

Alain CharestHarvard Medical School

USA

Marsha A MosesHarvard Medical School

USA

Sid KatugampolaCentre for Drug Development at

Cancer, UK

Christian TiedeThe University of Leeds

UK

Jack C WestmanUniversity of Wisconsin School of Medicine and Public Health, USA

Bobbie Jo M Webb RobertsonPacific Northwest National Laboratory

USA

Kirti KaulSenior Scientist Medbiomarkers

Germany

Alvaro Macieira-CoelhoFrench National Institute of Health

France

Sabine MaiUniversity of Manitoba

Canada

Jens WiltfangGeorg August University Göttingen

Germany

Dimitrios H. RoukosCentre for Biosystems & Synthetic

Genomic Network Medicine, Greece

Liane DeligdischMount Sinai School of Medicine

USA

Nichola C GarbettUniversity of Louisville School of

Medicine, USA



Previous Speakers

Bo YuanTokyo University of Pharmacy and

Life Sciences, Japan

Yoshiaki OmuraNew York Medical College

USA

Seung-Cheol LeeUniversity of Pennsylvania

USA

Raffaella SordellaCold Spring Harbor Laboratory

USA

Katharina PachmannSIMFO GmbH

Germany

Shahid GilaniUniversity Hospital of North

Midlands, UK

Jessie Qiaoyi LiangThe Chinese University of

Hong Kong, China

Javier CamachoCINVESTAV

Mexico

Olivier E PardoImperial College London

UK

John LovecchioNorthwell School of Medicine

USA

Ciro Roberto RinaldiUniversity of Lincoln

UK

Jiri VachtenheimCharles University in Prague

Czech Republic

Ella L KimJohannes Gutenberg University

Medical Centre, Germany

Amy McCulloughAmerican Humane Association

USA

Zhongxing LiangEmory University

USA

Stefana Oana PurcaruUniversity of Medicine and Pharmacy

of Craiova, Romania

Steven ChamowChamow & Associates Inc.

USA

Kinjal PatelBristol-Myers Squibb

USA

Larysa M SkivkaTaras Shevchenko National

University, Ukraine

Elke WaglerPleißental-Klink Werdau

Germany



Why to Attend???JoinyourpeersaroundtheworldfocusedonlearningaboutCancerBiomarkersandMolecularBiomarkersrelatedadvances,whichisyoursinglebestopportunitytoreachthelargestassemblageofparticipantsfromtheCancerBiomarkerscommunity,conductdemonstrations,distributeinformation,meetwithcurrentandpotentialprofessionals,makeasplashwithanewresearchworks,andreceivenamerecognitionatthis3-dayevent.World-renowned speakers, themost recent research, advances, and the newest updates in CancerBiomarkersandMolecularBiomarkersarehallmarksofthisconference.

AtBiomarkersCongress2017meetyourtargetaudiencesfromaroundtheworldfocusedonlearningaboutCancerBiomarkersandMolecularBiomarkers.ThisconferencewouldbeyoursinglebestopportunitytoreachthelargestassemblageofparticipantsfromtheCancerBiomarkersandMolecularBiomarkerscommunity.

Abstract Information: Oral / Poster Presentation GuidelinesOralPresentationsaregenerallysplitintoTWOcategories,asfollows:

1.PlenaryLectures• EachPlenarylectureis25minutesinlengthandcomprisesonepresentation.Werecommendyouplantopresentforapproximately20minuteswith5minutesforquestions/discussion.

• WherePlenaryLectures arepresentedasdebates, eachof two speakers shouldplan topresent for20minutes,allowingfiveminutesforclosingquestionsandconclusions.WerecommendthatinvitedspeakerscommunicateinadvanceoftheModeratorsothatpresentationsmaybecoordinated.

2.OralSessions• EachOral Session is 60minutes in length and comprises two presentations, of 30minutes each. Werecommendthatyouplantopresentforapproximately15minutes,allowingtimeforquestions/discussionattheendofthepresentation.

Pleaseprepareyoupresentationin16:9format(screenareinformat16:9).WerecommendyoutosaveyourPowerPointpresentationusingPPT(X)formatinsteadofPPS.

Atechnicianisavailableineverysessionroomtoprovideassistancewhenneeded.Duetotheonlinepresentationsystem,allspeakersarekindlyrequestedtouseprovidedPConsite.Pleasebepresentinthesessionroom15minutespriorthestartofyoursessionandfollowtheinstructionsfromtheChairsand/ortechnician.Duringyour presentation a remote controlwill be available for controlling your presentation. Please observe thetimeallottedtoyouasyouwillnotbepermittedtospeakfor longertime.AttheendoftheCongress,allpresentationswillbedeletedfromthepresentationsystemandcomputerson-site.

SpeakerPreviewRoom

AllspeakersareaskedtouploadtheirpresentationattheSpeakerPreviewRoom(locatedintheRegistrationarea)atleastonehourbeforethebeginningofthesessionorthedaybeforeincaseofamorningsession.



Poster GuidelinesTheposterexhibitionwillbeanintegralpartofMedPharmaCongress.

Theposterexhibitionwillbelocatedontheexhibitionareaofthecongresscentre.Theareawillbeclearlysignpostedfromtheregistrationarea.

TechnicalInstructions:•PostersmustbepreparedinPortraitstyle.•PleaseDONOTpreparealandscapeposter•Thedimensionsshouldbe100cmhighby70cmwide•Postersshouldbeattachedtotheboardswithstickers,whichyouwillbesuppliedtotheorganizers.•PostersessionschedulePosterswillbedisplayedandpresentedinsession.

Pleaseplantobeatyourposterandavailabletoanswerquestionsfromdelegatesatthetimeofyourassignedpostersession.PosterswillbedisplayedaccordingtothePOSTERnumbersgivenbytheorganizersandwillbegroupedbysubtopic.

Young Researchers ForumTheYoungResearchersForumoffersyoungresearchersthepossibilitytomeetanddiscussresearchtopicsandmethodologies,shareanddevelopideas,learnfromeachotherandgainknowledgefromseniorresearchers.

YoungResearcher Sessions are organized at theMedPharmaCongress, toprovide auniqueplatform forYoung Researchers/Investigators for presenting latest research projects with an in-depth analysis. YoungInvestigators(e.g.Post-Graduatestudents,Post-doctoralfellows,Trainees,Juniorfaculty)arethefocusofthisevent.Participantsshouldbebelowtheageof33years.AllsubmissionsmustbeinEnglish.

Theprizewinningpaperswillbeconsideredforpublicationintheinternationaljournalsoncethepaperissubjectedtostandardreviewprocedures.

Forfurtherinformationpleasecontact:[email protected]



Registration InformationHowToRegister

Website:http://molecular-cancer-biomarkers.conferenceseries.com/asiapacific/registration.php

Registration Fees• Earlyregistrationfee:$799

• (SAVE$100.00—DEADLINE:January30,2017)

• Regularregistrationfee:$899

• SAVE$100.00—August30,2017throughJune27,2017)

• Lateregistrationfee:$999

• DiscountsonGroupRegistrations

• StudentRegistration:$399

• YoungResearchersForumFee:500$

Cancellation PolicyCancellationsmustbereceivedinwriting60dayspriortothemeetingandaresubjecttoa$100processingfee.Refundswill notbegranted afterAugust 26, 2017, norwill theybegiven forno-shows. Please [email protected]

AccommodationsHyattRegencyOsaka1-13-11Nanko-KitaSuminoe-KuOsakaJapan559-0034

Tomakereservationsandensurethatyouwillhaveahotelroomatthesamelocationastheconference,pleasechoose your package and register at http://molecular-cancer-biomarkers.conferenceseries.com/asiapacific/registration.php

PaymentsWeacceptVisa,MasterCard,AmericanExpressandchecks.Ifpayingbycreditcard,pleaseutilizeouronlineregistrationsitelocatedathttp://molecular-cancer-biomarkers.conferenceseries.com/asiapacific/registration.phpIfyouwishtopaybycheck,pleasecontactbiomarkercongress@cancersummit.orgFormoreinformation:Questions?Contact1(650)8894686orinquiries:[email protected]://molecular-cancer-biomarkers.conferenceseries.com/asiapacific/

Stay Connected Before, During and After the Event!



Day1:October26,2017OpeningCeremony

ConferenceSouvenirLaunchNewPerspectivefrontiersintheareaofCancerBiomarkersandMolecularBiomarkersKeynoteForum(&ExhibitionsFullday)(PaneldiscussionsandReviews)CoffeeBreak:Networking&RefreshmentsGroupPhoto

SpeakerForumSessionsChair’sIntroductionTrack1:MolecularBiomarkersDiscoveryTrack2:TranslationalBiomarkersTrack3:Biomarkers:ValidationandVerificationTrack4:ClinicalbiomarkersTrack5:Biomarkers:CancersPaneldiscussionsandReviews

LunchBreakYoungResearchForum(PaneldiscussionsandReviews)CoffeeBreak:Networking&RefreshmentsB2BMeetingsCertificatesFelicitationbytheorganizingCommittee

Day3:October28,2017Introduction

KeynoteForum(&ExhibitionsFullday)(PaneldiscussionsandReviews)CoffeeBreak:Networking&Refreshments

SpeakerForumSessionsChair’sIntroductionTrack11:CompanionDiagnosticsTrack12:BiomarkersandPharmacologyTrack13:MolecularImagingandDynamicsPaneldiscussionsandReviewsYoungResearchForum(PaneldiscussionsandReviews)

LunchbreakSpeakerSessions(Cont…)PosterSessionsEvaluationbytheCommitteeRefreshmentsAwardCeremonyFelicitationofthebestposterawards

ClosingCeremony

Day2:October27,2017Introduction

KeynoteForum(&ExhibitionsFullday)(PaneldiscussionsandReviews)CoffeeBreak:Networking&Refreshments

SpeakerForumSessionsChair’sIntroductionTrack6:BiomarkersandDiseasesTrack7:CellfreebiomarkersTrack8:PredictiveCancerBiomarkersTrack9:AdvancesofBiomarkerTestingTrack10:BiomarkerandPersonalizedMedicinePaneldiscussionsandReviews

LunchBreakYoungResearchForum(PaneldiscussionsandReviews)CoffeeBreak:Networking&RefreshmentsB2BMeetingsCertificatesFelicitationbytheorganizingCommittee

Program



Glimpses of Biosimilars 2016



Media Partners @ Biomarkers Congress 2017



Plan your Trip to Osaka7 UNESCO World Heritage Sites

Universal Studios Nakanoshima

Amusement A Tree House

Harry Potter Hogwarts Kyoto

Osaka Castle Osaka Skyline

Contact [email protected]

Submit your abstract online at: http://molecular-cancer-biomarkers.conferenceseries.com/asiapacific/abstract-submission.php

Register online:http://molecular-cancer-biomarkers.conferenceseries.com/asiapacific/registration.php

About JapanJapan is a world apart – a cultural Galápagos where a unique civilization blossomed, and today thrives in contrasts of traditional and modern. The Japanese spirit is strong, warm and incredibly welcoming. Japan is a leading nation in scientific research, particularly technology, machinery and biomedical research. Ja-pan leads the world in robotics production and use. Osaka is the second largest metropolitan area in Japan and serves a major economic hub. Historically a merchant city, Osaka has also been known as the “Nation’s Kitchen”. With a population of 2.5 million, Osaka is Japan’s third largest and second most important city. It has been the economic powerhouse of the Kansai region for many centuries. The city’s west side has the main port as well as a tourist destination with attractions such as Kyocera Dome, Universal Studios Japan, Osaka aquarium, Minami, Osaka castle, Umeda sky buildingand the TempozanHarbour Village. Osaka is known for its food, both in Japan and abroad. Author Michael Booth and food critic François Simon of Le Figaro have both suggested that Osaka is the food capital of the world.Osaka’s culinary prevalence is the result of a location that has provided access to high quality ingredients, a high population of merchants, and close proximity to the ocean and waterway trade.In recent years, Osaka has started to garner more attention from foreigners with the increased popularity of cooking and dining in popular culture.

The National Museum of Art (NMAO) is a subterranean Japanese and international art museum, hous-ing mainly collections from the post-war era and regularly welcoming temporary exhibitions. Osaka Sci-ence Museum is in a five storied building next to the National Museum of Art, with a planetarium and an OMNIMAX theatre. The Museum of Oriental Ceramics holds more than 2,000 pieces of ceramics, from China, Korea, Japan and Vietnam, featuring displays of some of their Korean celadon under natural light.The Osaka Museum of History, opened in 2001, is located in a 13-story modern building providing a view of Osaka Castle. Its exhibits cover the history of Osaka from pre-history to the present day. Osaka Museum of Natural History houses a collection related to natural history and life.

9th international conference on biomarkers

Documents